| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.846 | 21.143 | 23.847 | 28.802 | 24.455 | 14.802 | 8.480 | 97.314 | 101.829 | 129.870 |
| Total Income - EUR | 18.847 | 21.143 | 23.847 | 28.802 | 24.455 | 14.802 | 8.480 | 97.336 | 101.861 | 129.877 |
| Total Expenses - EUR | 9.762 | 11.868 | 7.958 | 7.137 | 9.017 | 16.142 | 13.275 | 64.969 | 71.929 | 82.876 |
| Gross Profit/Loss - EUR | 9.085 | 9.275 | 15.889 | 21.665 | 15.439 | -1.340 | -4.795 | 32.367 | 29.932 | 47.001 |
| Net Profit/Loss - EUR | 8.519 | 8.640 | 15.174 | 20.801 | 14.705 | -1.765 | -5.050 | 31.394 | 28.913 | 43.183 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Crisderma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.416 | 2.559 | 1.926 | 2.133 | 1.596 | 1.129 | 724 | 2.953 | 1.223 | 1.899 |
| Current Assets | 7.567 | 6.645 | 13.878 | 19.290 | 34.223 | 12.340 | 7.233 | 38.913 | 46.749 | 46.567 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 41 | 46 | 52 | 485 | 510 | 500 | 489 | 25.152 | 3.769 | 30.186 |
| Cash | 7.526 | 6.599 | 13.825 | 18.805 | 33.713 | 11.840 | 6.744 | 13.761 | 42.980 | 16.382 |
| Shareholders Funds | 8.564 | 8.685 | 15.218 | 20.844 | 35.145 | 12.702 | 7.371 | 31.434 | 35.820 | 43.223 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 419 | 524 | 586 | 579 | 674 | 766 | 586 | 10.432 | 12.152 | 5.243 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crisderma Srl